Continuous Renal Replacement Therapy (CRRT) Market 2022-2028

Description

List of Tables

Title:Global Continuous Renal Replacement Therapy (CRRT) Market Size, Share & Trends Analysis Report by Product (Dialysates and Replacement Fluids and Disposables), by Modality (Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodiafiltration (CVVHDF), Continuous Venovenous Hemodialysis (CVVHD), Slow Continuous Ultrafiltration (SCUF)), and by Age-Group (Adults and Pediatrics /Neonates) Forecast Period (2022-2028).

The global CRRT market is projected to grow at a modest CAGR of nearly 5.8% during the forecast period. The key aspect that drives the growth of the market includes the rising prevalence of AKI coupled with the increased incidence of sepsis. For an instance, in an article published by the International Society of Nephrology 2020, countries such as China and India reported an AKI rate of 29% in 2019.

The global CRRT market is segmented based on product, modality, and age-group. Based on product, the market is segmented as dialysates and replacement fluids, and disposables. The disposables segment further includes hemofilter, bloodline sets and tubes, and other disposables. Based on modality, the market is segmented into continuous venovenous hemofiltration (CVVH), continuous venovenous hemodiafiltration (CVVHDF), continuous venovenous hemodialysis (CVVHD), and slow continuous ultrafiltration (SCUF). Among the modality, the Continuous Venovenous Hemofiltration (CVVH) segment is expected to be the fastest-growing segment during the forecast period. Based on age group, the market is segmented as adults, and pediatrics /neonates.

Geographically, the global CRRT market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific region is projected to hold a significant market share. China, India, Japan, and the Rest of the Asia-Pacific are the major economies primarily contributing to the growth of the continuous renal replacement therapy market in the region. The regional growth of the market is accredited to government initiatives to spread awareness of renal therapy in the economies such as China and India. North America held a major market position in the global continuous renal replacement therapy market.

Further, Medtronic plc, Baxter International Inc., and Fresenius Medical Care AG & CO. KGaA among others are some of the prominent players operating in the market. Strategic initiatives along with competitive pricing may support an increase in the market share of the players during the forecast period. Manufacturers are extensively investing in new technologies. Moreover, new launches & developments, partnerships, collaborations, and mergers and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market. For an instance, in 2019, Fresenius Medical Care AG & CO. KGaA announced the launch of the 4008A dialysis machine in India.

Research Methodology

The market study of the global continuous renal replacement therapy (CRRT) market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

Financial reports of companies involved in the market

Whitepapers, research papers, and news blogs

Company websites and their product catalog

The report is intended for continuous renal replacement therapy (CRRT) companies, manufacturing companies, retail companies, healthcare companies, government organizations, transportation, and logistics companies, software companies, research institutes and universities, other related companies, and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

Global Continuous Renal Replacement Therapy (CRRT) Market Research and Analysis by Product.

Global Continuous Renal Replacement Therapy (CRRT) Market Research and Analysis by Modality.

Global Continuous Renal Replacement Therapy (CRRT) Market Research and Analysis by Age-Group.

The Report Covers:

Comprehensive research methodology of the global continuous renal replacement therapy (CRRT) market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global continuous renal replacement therapy (CRRT) market.
Insights about market determinants that are stimulating the global continuous renal replacement therapy (CRRT) market.
Detailed and extensive market segments with regional distribution of forecast revenues.
Extensive profiles and recent developments of the market player.

Product Code: OMR2026641

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the Global CRRT Industry
Recovery Scenario of Global CRRT Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Conclusion
2.3. Porter's Analysis

3. Competitive Landscape

3.1. Key Company Analysis
- 3.1.1. Baxter International Inc.
  - 3.1.1.1. Overview
  - 3.1.1.2. Financial Analysis
  - 3.1.1.3. SWOT Analysis
  - 3.1.1.4. Recent Developments
- 3.1.2. Fresenius Medical Care AG & CO. KGaA
  - 3.1.2.1. Overview
  - 3.1.2.2. Financial Analysis
  - 3.1.2.3. SWOT Analysis
  - 3.1.2.4. Recent Developments
- 3.1.3. Medtronic PLC
  - 3.1.3.1. Overview
  - 3.1.3.2. Financial Analysis
  - 3.1.3.3. SWOT Analysis
  - 3.1.3.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on Key Players

4. Market Segmentation

4.1. Global CRRT Market by Product
- 4.1.1. Dialysates and Replacement Fluids
- 4.1.2. Disposables
  - 4.1.2.1. Hemofilters
  - 4.1.2.2. Bloodline Sets & Tubes
  - 4.1.2.3. Other Disposables
4.2. Global CRRT Market by Modality
- 4.2.1. Continuous Venovenous Hemofiltration (CVVH)
- 4.2.2. Continuous Venovenous Hemodiafiltration (CVVHDF)
- 4.2.3. Continuous Venovenous Haemodialysis (CVVHD)
- 4.2.4. Slow Continuous Ultrafiltration (SCUF)
4.3. Global CRRT Market by Age-Group
- 4.3.1. Adults
- 4.3.2. Pediatrics /Neonates

5. Regional Analysis

5.1. North America
- 5.1.1. US
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. Anjue Medical Equipment Co., Ltd.
6.2. Asahi Kasei Corp.
6.3. B. Braun Melsungen AG
6.4. Baxter International Inc.
6.5. Fresenius Medical Care AG & Co. KGaA
6.6. Infomed SA
6.7. Medica S.p. A.
6.8. Medical Components, Inc.
6.9. Medites Pharma spol. s.r.o.
6.10. Medtronic plc
6.11. NIKKISO CO., LTD.
6.12. Ningbo Tianyi Medical Devices Co., Ltd.
6.13. Nipro Corp. Ltd.
6.14. NxStage Medical, Inc.
6.15. Proxima Medicare
6.16. SWS Hemodialysis Care Co., Ltd.
6.17. Toray Medical Co., Ltd.